Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Creon 25000 Minimicrospheres versus placebo in adults with pancreatic exocrine insufficiency
2005-004854-29Phase 4Completed
- Sponsor
- Abbott Laboratories
- Start
- Mar 2007
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes, Blood Coagulation Factors → Therapeutic Enzymes → Recombinant Proteins and Enzymes, Insulin and Analogs → Hormones & Growth Factors → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in exocrine pancreatic insufficiency (EPI) comparing Creon with Placebo (2 arms). Primary endpoint: Change in coefficient of fat absorption. Started Mar 2007; status: completed.
02
Drugs
pancreatin
03
Conditions
exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on 2005-004854-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004854-29.